Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FSPHX vs. XLV: which is better?

Bottom line

FSPHX vs XLV: the short answer

FSPHX (Health Care Portfolio) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But FSPHX is far broader, holding 152 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.62% — a difference of $54 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +4.0% for FSPHX (reporting dates differ).

Updated Nov 19, 2026

FSPHX vs XLV side by side

FSPHXXLV
TypeMutual fundETF
Fund familyFidelitySPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.62%0.08%
Annual cost per $10k$62$8
10-yr cost on $10k (prospectus)$774$103
Max front load—None
12b-1 fee0%0.02%
1-yr return+14.4%+14.5%
5-yr return (annualized)+4.0%+8.1%
10-yr return (annualized)+9.0%+9.8%
Best quarter+22.2%+14.5%
Worst quarter−15.0%−12.7%
Net assets (fund)$5.8B$40.6B
Number of holdings15265
Portfolio turnover69%2%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFSPHXXLVDifference
2025+14.4%+14.5%−0.1%
2024+4.9%+2.5%+2.4%
2023+4.1%+2.0%+2.1%
2022−12.8%−2.1%−10.8%
2021+11.5%+25.9%−14.4%
2020+24.4%+13.3%+11.2%
2019+31.5%+20.7%+10.8%
2018+7.4%+6.3%+1.1%
2017+24.0%+21.7%+2.3%
2016−10.7%−2.8%−7.9%

Source: Fund prospectus bar charts

Holdings overlap

11 of FSPHX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingFSPHXXLV
ELI LILLY and CO8.03%16.51%
Danaher Corp6.89%2.09%
JOHNSON and JOHNSON4.91%10.64%
Thermo Fisher Scientific Inc4.33%3.24%
Unitedhealth Group Inc3.49%6.57%
Gilead Sciences Inc2.21%2.73%
Boston Scientific Corp2.17%1.10%
Abbvie Inc2.03%7.74%
MERCK and CO INC1.60%5.52%
Cvs Health Corp1.29%2.30%
Cencora Inc1.14%0.96%

Source: SEC Form N-PORT

FSPHX top 10

  1. ELI LILLY and CO — 8.03%
  2. Danaher Corp — 6.89%
  3. JOHNSON and JOHNSON — 4.91%
  4. Thermo Fisher Scientific Inc — 4.33%
  5. Unitedhealth Group Inc — 3.49%
  6. Alnylam Pharmaceuticals Inc — 2.40%
  7. Gilead Sciences Inc — 2.21%
  8. Boston Scientific Corp — 2.17%
  9. Ascendis Pharma A/s — 2.17%
  10. Fidelity Revere Street Trust — 2.17%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between FSPHX and XLV?
FSPHX (Health Care Portfolio) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But FSPHX is far broader, holding 152 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, FSPHX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both FSPHX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.